My Blog
Business

NextEra, Danaher, Rhythm Pharmaceuticals and more

NextEra, Danaher, Rhythm Pharmaceuticals and more
NextEra, Danaher, Rhythm Pharmaceuticals and more


Wind turbines at the San Gorgonio Pass wind farm, owned by NextEra Energy Inc., in Whitewater, California, on Wednesday, Feb. 17, 2021.

Bing Guan | Bloomberg | Getty Images

Check out the companies making headlines after hours.

NextEra Energy — Shares fell 3% in extended trading after the company announced its intent to sell $2 billion in equity units. Each equity unit will be issued in the amount of $50 and will consist of a contract to purchase NextEra Energy common stock in the future, as well as a 5% undivided beneficial ownership interest in a NextEra Energy Capital Holdings debenture due Sept. 1, 2027, issued in the principal amount of $1,000.

Danaher — The medical company saw shares rise 4% after announcing plans to spin off its environmental and applied solutions business to create an independent, publicly traded company. It also raised its third-quarter revenue guidance, according to FactSet.

Rhythm Pharmaceuticals — Shares of Rhythm Pharmaceuticals fell about 11% after the company announced a $100 million stock offering.

Arconic Corp — The manufacturing company’s shares slid about 8% after Arconic provided a lower-than-previously-expected revenue forecast for the full year, citing the impact of operational issues and the combination of demand declines and higher unhedged energy costs in Europe.

Related posts

Scopia Capital pushes for strategic review at Verra Mobility. Here’s why it’s an unusual request

newsconquest

Judge extends restraining order on Biden plan

newsconquest

The job market is hot this summer and teens are taking advantage

newsconquest